
Previously held in Munich, this year’s event
will give presenting companies and delegates alike the opportunity to
meet and network with not only the key players in the Swiss banking funds
community, but also the leading names in big pharma and bio. The event
annually attracts over 400 industry players and features executive roundtables,
interspersed with presentations by life science companies. This year the
event will feature many of the leading players in global biotech including
representatives of those involved in bringing recent IPOs Basilea and
Ark Therapeutics to the market. Presenting companies
that have signed up to present at this event already include:
|
|
Presenting at this forum offers excellent opportunities
to showcase your company to some of the leading global investors and corporates.
It will offer you the opportunity to communicate your projected capital
raising plans or simply help you in finding the right partner for your
business. Sachs-Bloomberg conferences have a strong track record of successfully
bringing together emerging growth companies and investors. We are offering
a strictly limited number
of presenting opportunities to small cap listed companies and IPO candidates
to present in a highly prominent position in the programme in the early
morning of the conference (approx. 11.00 – 12.30am). We accept applications
on a first come – first served basis and as such, those received
first are given prior consideration.
For further information or to apply to present at the forum,
please do not hesitate to contact us on + 44 20 7405 5544, hl@sachsforum.com
Last year’s event attracted over 350 delegates from
international pharmas and biotechs.
Presenting companies included:
Ace BioSciences • Amarin Corporation
plc • AMT B.V. • Androclus Therapeutics • Arakis Ltd
• ARPIDA Ltd • Artesian Therapeutics • atugen AG •
Avidex Limited • Avontec GmbH • Borean Pharma A/S •
Chiral Quest • CombinatoRx, Inc • Cyclacel Ltd • Cytochroma
Inc. • DeveloGen • EUROPROTEOME AG • Favrille, Inc.
• Gamida-Cell Ltd • Global Genomics AB • Intercell AG
• IntegraGen S.A. • LifePoint, Inc. • Lorantis •
MacroPore Biosurgery, Inc. • Micromet AG • Newron Pharmaceuticals
S.p.A. • Nuevolution A/S • Opexa Pharmaceuticals, Inc. •
Oxagen • Perlegen Sciences, Inc. • PIERIS Proteolab AG •
Rejuvenon Corp. • Salmedix, Inc. • SIGA Technologies Inc.
• TeGenero AG • The Genetics Company • Trigen Ltd. •
Vecta Ltd. • Xantos Biomedicine AG
back to top |